Nucleoprotein is methylated by PRMT1

Stable Identifier
R-HSA-9729283
Type
Reaction [transition]
Species
Homo sapiens
Related Species
Severe acute respiratory syndrome coronavirus 2
Compartment
cytosol
ReviewStatus
5/5
Locations in the PathwayBrowser
Expand all
General
SVG | 
PNG
Low
Medium
High
 | PPTX  | SBGN
Nucleoprotein is methylated by PRMT1
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
Protein arginine methyltransferase 1 (PRMT1) methylates SARS-CoV-2 nucleoprotein on two arginines (R95 and R177). This modification is required for its RNA binding capacity, since treatment with a type I PRMT inhibitor (MS023) or substitution of R95K or R177K inhibited interaction with the 5’-UTR of the SARS-CoV-2 genomic RNA. Pre-treatment of VeroE6 cells with MS023 significantly reduced SARS-CoV-2 replication (Cai et al, 2021).
Literature References
PubMed ID Title Journal Year
34029587 Arginine methylation of SARS-Cov-2 nucleocapsid protein regulates RNA binding, its ability to suppress stress granule formation, and viral replication

Richard, S, Liang, C, Wang, Z, Yu, Z, Cai, T

J Biol Chem 2021
Participants
Input
Output
Participates
as an event of
Catalyst Activity

protein-arginine omega-N asymmetric methyltransferase activity of PRMT1 [cytosol]

Physical Entity
PRMT1 [cytosol] (Homo sapiens)
Activity
protein-arginine omega-N asymmetric methyltransferase activity (GO:0035242)
This event is regulated
Negatively by
Regulator
PRMT1:type I PRMT inhibitors [cytosol] (Homo sapiens)
Disease
Name Identifier Synonyms
COVID-19 DOID:0080600 2019 Novel Coronavirus (2019-nCoV), Wuhan seafood market pneumonia virus infection, 2019-nCoV infection, Wuhan coronavirus infection
Authored
Stephan, R  (2021-04-22)
Reviewed
Acencio, ML  (2021-05-09)
Created
Stephan, R  (2021-04-28)
Cite Us!